Who owns TSCAN THERAPEUTICS INC?
- Ticker: TCRX
- CUSIP Number: 89854m101
Tip: Access positions for across all investors
Analyze quarterly positions in Tscan Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tscan Therapeutics stock
Who bought or sold TSCAN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Lynx1 Capital Management | 8.0M | $7.9M | 0% | Jun 2026 |
|
| BVF | 5.6M | $5.5M | 0% | Jun 2026 |
|
| Baker Bros. Advisors | 2.8M | $2.7M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 2.2M | $2.1M | 0% | Jun 2026 |
|
| Two Sigma Investments | 1.9M | $1.9M | 61% | Jun 2026 |
|
| Renaissance Technologies | 1.3M | $1.3M | -3% | Jun 2026 |
|
| Acadian Asset Management | 1.3M | $1.3M | 546% | Jun 2026 |
|
| Deer Management | 1.2M | $1.2M | 0% | Jun 2026 |
|
| Millennium Management | 1.2M | $1.1M | -20% | Jun 2026 |
|
| Jacobs Levy Equity Management | 1.0M | $1.0M | 30% | Jun 2026 |
|
| Citadel Advisors | 1.0M | $989k | 217% | Jun 2026 |
|
| BlackRock | 995k | $975k | -46% | Jun 2026 |
|
| Boothbay Fund Management | 772k | $757k | 100% | Jun 2026 |
|
| Marshall Wace | 687k | $674k | 190% | Jun 2026 |
|
| DC Funds | 630k | $618M | 0% | Jun 2026 |
|
| Geode Capital Management | 585k | $574k | -5% | Jun 2026 |
|
| D. E. Shaw & Co | 548k | $538k | 72% | Jun 2026 |
|
| GSA Capital Partners | 548k | $537k | 45% | Jun 2026 |
|
| Kalehua Capital Management | 455k | $446k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 364k | $357k | 19% | Jun 2026 |
|
| Jane Street | 242k | $237k | 67% | Jun 2026 |
|
| Verdad Advisers | 233k | $228k | 74% | Jun 2026 |
|
| State Street Corporation | 207k | $209k | 0% | Mar 2026 |
|
| Mizuho Securities Usa | 206k | $202k | 100% | Jun 2026 |
|
| Morgan Stanley | 174k | $175k | -23% | Mar 2026 |
|
| Hrt Financial | 165k | $161k | 100% | Jun 2026 |
|
| XTX Topco | 150k | $147k | 146% | Jun 2026 |
|
| Brown Brothers Harriman & Co. | 143k | $140k | 0% | Jun 2026 |
|
| Northern Trust | 139k | $136k | 42% | Jun 2026 |
|
| Letko, Brosseau & Associates | 96k | $94k | 0% | Jun 2026 |
|
| NewEdge Wealth | 92k | $90k | 0% | Jun 2026 |
|
| Bridgeway Capital Management | 77k | $75k | -31% | Jun 2026 |
|
| Goldman Sachs Group | 71k | $69k | 89% | Jun 2026 |
|
| Ameriprise Financial | 70k | $68k | 32% | Jun 2026 |
|
| UBS Group | 69k | $68k | 112% | Jun 2026 |
|
| Stifel Financial | 68k | $67k | -2% | Jun 2026 |
|
| Dimensional Fund Advisors | 65k | $64k | 0% | Jun 2026 |
|
| Kestra Advisory Services | 63k | $61k | 0% | Jun 2026 |
|
| Bank of America Corporation | 49k | $48k | -15% | Jun 2026 |
|
| Ohio Pers | 37k | $36k | 32% | Jun 2026 |
|
| Dean Capital Investments Management | 36k | $35k | 0% | Jun 2026 |
|
| Landscape Capital Management | 26k | $25k | 100% | Jun 2026 |
|
| Hsbc Holdings | 25k | $24k | 0% | Jun 2026 |
|
| Susquehanna International | 24k | $23k | -85% | Jun 2026 |
|
| Barclays | 19k | $19k | 12% | Jun 2026 |
|
| R Squared | 18k | $18k | 100% | Jun 2026 |
|
| JustInvest | 18k | $18k | -16% | Jun 2026 |
|
| Jpmorgan Chase & Co | 17k | $16k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 16k | $15k | 0% | Jun 2026 |
|
| Advisor Group Holdings | 12k | $12k | 26% | Jun 2026 |
|
| Aries Wealth Management | 10k | $9.8k | 0% | Jun 2026 |
|
| Global Retirement Partners | 10k | $9.8k | 100% | Jun 2026 |
|
| Federated Investors | 4.0k | $3.9k | -7% | Jun 2026 |
|
| Tower Research Capital | 2.5k | $2.5k | -50% | Jun 2026 |
|
| FMR | 1.4k | $1.4k | 8% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 713.00 | $699.025200 | 0% | Jun 2026 |
|
| SBI Securities | 392.00 | $384.003200 | 0% | Jun 2026 |
|
| Strategic Wealth Partners | 311.00 | $304.997700 | 0% | Jun 2026 |
|
| Royal Bank of Canada | 78.00 | $0 | 7% | Jun 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | -50% | Jun 2026 |
|
| Citigroup | 1.00 | $1.000000 | 100% | Mar 2026 |
|
Who sold out of Tscan Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Standard Life Aberdeen | Mar 2026 | 918k | $927k |
| Nine Masts Capital | Mar 2026 | 42k | $42k |
| Prudential Financial | Mar 2026 | 30k | $30k |
| PanAgora Asset Management | Mar 2026 | 29k | $29k |
| LPL Financial | Mar 2026 | 23k | $23k |
| Virtu Financial | Mar 2026 | 18k | $18k |